NASDAQ : BYAH
Park Ha Biological Technology Co., Ltd. — Key statistics
Consumer Staples · Household & Personal Products · China
Last price 2.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 7.88M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 7.57M |
| Enterprise Value | 2.10M |
Dates
| Measure | Value |
|---|
| Earnings Date | Jul 24, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 3.38M |
| Shares Outstanding | 3.43M |
| Shares Change (YoY) | +231.60% |
| Shares Change (QoQ) | +337.70% |
| Owned by Insiders (%) | 8.41% |
| Owned by Institutions (%) | 0.20% |
| Float | 3.00M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.98 |
| Forward PS | n/a |
| PB Ratio | 0.25 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.36 |
| Quick Ratio | 2.82 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -215,834.04 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -113.04% |
| Return on Assets (ROA) | -50.74% |
| Return on Invested Capital (ROIC) | -3,410.26% |
| Return on Capital Employed (ROCE) | -99.09% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $62,033 |
| Profits Per Employee | -$132,855 |
| Employee Count | 41 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.53 |
Taxes
| Measure | Value |
|---|
| Income Tax | 90,480 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -98.56% |
| 50-Day Moving Average | 2.49 |
| 200-Day Moving Average | 10.85 |
| Relative Strength Index (RSI) | 42.25 |
| Average Volume (20 Days) | 197,832 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 29,583 |
| Short Previous Month | 22,259 |
| Short % of Shares Out | 0.86% |
| Short % of Float | 0.99% |
| Short Ratio (days to cover) | 0.10 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.54M |
| Gross Profit | 2.41M |
| Operating Income | -5.40M |
| Pretax Income | -5.36M |
| Net Income | -5.45M |
| EBITDA | -5.21M |
| EBIT | -5.40M |
| Loss Per Share | -$25.33 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 5.66M |
| Total Debt | 186,331 |
| Net Cash | 5.47M |
| Net Cash Per Share | $1.60 |
| Equity (Book Value) | 5.39M |
| Book Value Per Share | 8.75 |
| Working Capital | 4.77M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -273,308 |
| Capital Expenditures | -311,677 |
| Depreciation & Amortization | 189,143 |
| Net Borrowing | -7,721 |
| Free Cash Flow | -584,985 |
| FCF Per Share | -$0.17 |
Margins
| Measure | Value |
|---|
| Gross Margin | 94.90% |
| Operating Margin | -212.16% |
| Pretax Margin | -210.61% |
| Profit Margin | -214.17% |
| EBITDA Margin | -204.72% |
| EBIT Margin | -212.16% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -231.60% |
| Shareholder Yield | -231.60% |
| Earnings Yield | -1,145.99% |
| FCF Yield | -7.73% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 6, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:8 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 24.45 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |